-
NIH Received $710 Million in Royalties From Drugmakers: Report; AI Insiders Warn of ‘Serious Risks’ Posed by the Tech | Business Matters Full Broadcast (June 4) -
Dow Sprints Past 40,000 on Rate-Cut Bets; Microsoft Asks Some China Staff to Relocate Amid Tensions | Business Matters Full Broadcast (May 16)
-
Washington State Reaches Nearly $150 Million Settlement With Johnson & Johnson Over Opioid Crisis
-
Lawsuits Claiming Tylenol Causes Autism Lack Scientific Support, Judge Finds
-
Sen. Hawley Grills Top Johnson & Johnson Attorney Over Liability Related to Cancer Claims
-
Pfizer, J&J Pressured South Africa Into Shielding Companies From COVID Vaccine Injury Claims: Documents
-
Johnson & Johnson’s Second Bankruptcy Attempt Fails—Why the Judge Ruled Against the Pharma Giant
-
Top 5 US Pharma Companies Netted $82 Billion in 2022: Report
-
J&J Must Pay $18.8 Million to California Cancer Patient in Baby Powder Suit
-
J&J Sues Biden Administration to Block Medicare Drug Price Negotiations
-
Johnson & Johnson’s $8.9 Billion Talc Settlement Faces US Bankruptcy Test
-
FDA Revokes Authorization for J&J COVID-19 Vaccine
-
Johnson & Johnson COVID-19 Vaccine Becomes Unavailable in US
-
Texas Attorney General to Investigate Whether COVID-19 Vaccine Makers Misled Public
-
Guillain-Barré Syndrome Linked to COVID-19 Vaccine: CDC Study
-
Court Rejects Johnson & Johnson Bankruptcy Strategy for Tens of Thousands of Baby Powder Lawsuits
-
J&J to Pay $40.5 Million to Settle New Hampshire Opioid Lawsuit
-
House Set to Pass Inflation Reduction Act; Peloton Laying Off 800 Employees | NTD Business
-
CDC Confirmed Post-Vaccination Death From Blood Clotting 2 Weeks Before Alerting Public: Emails
-
People Can Still Get J&J Vaccine If They Have a Problem With Other Two Shots: White House
-
FDA Restricts J&J’s COVID-19 Vaccine Over Risk of Blood Clots
-
Alabama Reaches $276M Settlement in Opioid Litigation
-
J&J Pulls COVID Vaccine Sales Forecast Due to Low Demand, Supply Glut
-
J&J to Stop Selling Personal Care Products in Russia
-
LA Expects to Receive Tens of Millions of Dollars from Opioid Settlement
-
Vaccine Maker Johnson & Johnson Settles Huge Lawsuit Over Role in Opioid Crisis
-
J&J Unit Proposes Independent Exam If It Remains in Bankruptcy
